A multicenter in vivo Japanese "transomics" analysis led by scientists at the University of Tokyo has revealed previously unknown allosteric and genetic regulatory axes underlying the altered hepatic glucose-responsive metabolism seen in obesity.
Keeping you up to date on recent developments in oncology, including: New theranostic nanoparticle design combines DNA wireframe and Sgc8c aptamer; Bolting TLR agonist to antibody converts cold tumors; Rule-based screening for degraders; How stress disrupts tumor cell sleep; Combo treatment shows efficacy in treatment of ALL.
Keeping you up to date on recent developments in cardiology, including: Addressing concerns regarding pharmacogenetic testing; Improving the nation's heart health; Researchers reveal genetic abnormalities that cause brain aneurysms.
An international study led by Nanyang Technological University in Singapore has designed and synthesized broad-spectrum antimicrobial polymers (AMPs) and demonstrated the safety and efficacy of two such agents against multidrug-resistant (MDR) bacteria in mouse models of sepsis.
Keeping you up to date on recent developments in neurology, including: AI developed to predict psychiatric diagnoses from Facebook activity; AIR coil from GE Healthcare shows promise for whole-brain imaging; Big data analysis suggests role of brain connectivity in epilepsy-related atrophy; Gestational age linked to ADHD in children with Down syndrome.
A study by Japanese scientists at the Okinawa Institute of Science and Technology has found that serotonergic neural projections to the brain's orbitofrontal and medial prefrontal cortices differentially modulate patience, as assessed by the time spent awaiting future rewards in mice.
PARIS – Researchers at the Biomechanics and Bioengineering laboratory (BMBI), a joint venture between the Compiègne University of Technology in Oise, France, and the National Center for Scientific Research (CNRS), have designed a new implant intended for minimally invasive surgery for mitral valve repair. One of the BMBI teams has been working closely two cardiovascular surgeons from the University Hospital of Henri-Mondor to develop this new minimally invasive approach in the treatment of mitral valve regurgitation.